EndoGastric Solutions

EndoGastric Solutions is a Redmond, WA based medical device company specialized in developing and commercializing incisionless surgical technology for gastroesophageal reflux disease (GERD). The company's flagship product, the Transoral Incisionless Fundoplication (TIF®) procedure, offers an innovative and minimally invasive solution for addressing this prevalent medical condition. The procedure has demonstrated promising results, including the elimination of esophageal inflammation up to three years post-procedure and a reduction in the need for daily medication. EndoGastric Solutions also offers the EsophyX® technology, a clinically backed tool for treating the underlying anatomical cause of GERD, providing potential long-term relief for patients. Established in 2003, EndoGastric Solutions operates in the Health Care industry and recently secured a significant $18.00M Venture Round investment in December 2022. While the details of the investors are not disclosed, the company's cutting-edge technology, commitment to addressing unmet clinical needs, and potential to revolutionize the treatment of GERD make it a compelling prospect for venture capital firms. Overall, EndoGastric Solutions' focus on evidence-based innovation in the field of gastroenterology and surgery positions it as a key player in the healthcare sector, with promising opportunities for growth and impact.